The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Obesity: a gender-view
Open accessAbstract
PURPOSE: There is a growing awareness of the importance of understanding gender differences in obesity. The aim of this short review was to revise the current evidence on anthropometric characteristics and nutritional and pharmacological aspects of obesity from a gender perspective. METHODS: A literature search within PubMed was performed. Selected publications related to obesity and gender differences were reviewed. RESULTS: The prevalence of obesity among men is higher than in women, but women have a higher percentage of body fat content compared to men, and gender appears to be an important factor in the manifestation of central (android) or peripheral (gynoid) obesity. In addition, while in most clinical trials, women are still underrepresented, in clinical registration trials of anti-obesity drugs, women are commonly up-represented and gender-specific analysis is uncommon. Considering that adipose tissue is one of the factors affecting the volume of distribution of many drugs, mainly lipophilic drugs, gender differences might be expected in the pharmacokinetics and pharmacodynamics of anti-obesity drugs. Indeed, although Liraglutide 3 mg, a long-acting glucagon-like peptide-1 receptor agonist, and naltrexone/bupropion display lipophilic properties, currently, a gender-dose adjustment for both these drugs administration is not recommended. In addition, despite that predicted responders to treatment offer substantial opportunities for efficient use, especially of expensive new therapies, such as anti-obesity drugs, data on gender differences to identify early responders to both these have not yet been investigated. Finally, bariatric surgery gender disparity reflects healthcare practices. Weight loss similar, but differing effects: women need more correction and face psychology challenges; men have worse physiology and fewer comorbidity improvements. CONCLUSION: Gender differences exist in obesity prevalence and phenotype, body fat distribution, drug efficacy, clinical trial representation, and different secondary effects of bariatric surgery. Gender is an important variable in obesity analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, a higher proportion of women participate in weight-loss clinical trials [106].”
From Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects (2025) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Obesity Among Adults in the United States, 2005 to 2014
Flegal, K. M., Kruszon-Moran, D., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2016) · JAMA · doi:10.1001/jama.2016.6458 · Cited by 2,803 · cited 1×
“According to the National Health and Nutrition Examination Survey (NHANES) 2005–2014, the prevalence of obesity among women is higher than among man, at 40% versus 35%, respectively [1].”
BackgroundObesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Gender differences in food choice: The contribution of health beliefs and dieting
Wardle, J., Haase, A. M., Steptoe, A., Nillapun, M., Jonwutiwes, K., & Bellisie, F. (2004) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2702_5 · Cited by 1,358 · cited 2×
“Dieting and the need for a healthier diet represented the main drivers behind women’s preferences [42].”
BackgroundResultPeterli, R., Wölnerhanssen, B. K., Peters, T., Vetter, D., Kröll, D., Borbély, Y., Schultes, B., Beglinger, C., Drewe, J., Schiesser, M., et al. (2018) · JAMA · doi:10.1001/jama.2017.20897 · Cited by 1,267 · cited 1×
“Regarding outcomes, there are minimal differences in weight loss between men and women after bariatric surgery [58, 63, 64].”
BackgroundSex differences in human adipose tissues – the biology of pear shape
Karastergiou, K., Smith, S. R., Greenberg, A. S., & Fried, S. K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-13 · Cited by 1,109 · cited 2×
“It has been shown that, given the same BMI, women have a 10% higher fat mass compared to men [34].”
BackgroundSex differences in metabolic regulation and diabetes susceptibility
Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J.-F., Montagner, A., & Gourdy, P. (2020) · Diabetologia · doi:10.1007/s00125-019-05040-3 · Cited by 923 · cited 2×
“It seems that female sex has a favorable effect on insulin sensitivity, despite women having higher adiposity relative to men [5].”
BackgroundThe sexual dimorphism of obesity
Palmer, B. F., & Clegg, D. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.029 · Cited by 919 · cited 1×
“Therefore, in women, the increased estrogen levels activate the sympathetic system and downregulate androgen receptor expression in the SAT, favoring fat deposition [28].”
BackgroundSuppressive effects of androgens on the immune system
Trigunaite, A., Dimo, J., & Jørgensen, T. N. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.02.004 · Cited by 551 · cited 2×
“Testosterone is suppressive of both the adaptive and innate immune responses [10], whereas estrogen may promote inflammatory responses [9].”
BackgroundSex Differences in Body Composition
Bredella, M. A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_2 · Cited by 523 · cited 2×
“Estrogen reduction during menopause is associated with the shift from gluteofemoral to central adipose tissue accumulation in women [30].”
BackgroundModulation of appetite by gonadal steroid hormones
Asarian, L., & Geary, N. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1860 · Cited by 514 · cited 2×
“Conversely, gonadectomized males reduce food intake [38].”
Background
Cited by
Obesity, Dietary Patterns, and Hormonal Balance Modulation: Gender-Specific Impacts
Mazza, E., Troiano, E., Ferro, Y., Lisso, F., Tosi, M., Turco, E., Pujia, R., & Montalcini, T. (2024) · Nutrients · doi:10.3390/nu16111629 · Cited by 128
“…has prompted numerous researchers to explore the gender-specific pathogenic mechanisms and phenotypic characteristics of obesity, aiming to discern gender-tailored weight loss strategies [17], especially considering the increasing prevalence of infertility in couples, attributed to both genders.”
BackgroundInfluentialWan, H., Cao, H., & Ning, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-66692-9 · Cited by 86
“Androgens are generally associated with more fat accumulation in the abdomen, whereas estrogens may influence fat accumulation in the buttocks and thighs 21 .”
BackgroundCao, X., Wang, N., Yang, M. J., & Zhang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146962 · Cited by 79
“Estrogen up-regulates PNPLA3 to promote TG storage in subcutaneous adipose tissue (SAT), whereas androgen increases the VAT/SAT ratio; sex hormones also influence eating style, with men preferring fats and women preferring carbohydrates [60].”
Social, cultural and ethnic determinants of obesity: From pathogenesis to treatment
Capoccia, D., Milani, I., Colangeli, L., Parrotta, M. E., Leonetti, F., & Guglielmi, V. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103901 · Cited by 67
Ayesh, H., Nasser, S. A., Ferdinand, K. C., & Leon, B. G. C. (2025) · Circulation Research · doi:10.1161/circresaha.124.325535 · Cited by 45
Metadata
- Authors
- Muscogiuri, G., Verde, L., Vetrani, C., Barrea, L., Savastano, S., & Colao, A.
- Affiliations
- University of Naples Federico II (IT)
- Federico II University Hospital (IT)
- Corresponding author
- Muscogiuri, G.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2023-09-23
- Volume
- 47
- Issue
- 2
- Pages
- 299-306
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- PMC
- PMC10859324
- OpenAlex
- W4386982751
- Cited by
- 164
- References
- 64
- Citations by year
- 2026: 63 · 2025: 66 · 2024: 34 · 2023: 1
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Napoli Federico II
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- obesity, gender differences, body fat distribution, android obesity, gynoid obesity, anti-obesity drugs, pharmacokinetics, pharmacodynamics, liraglutide, naltrexone/bupropion, GLP-1 receptor agonists, bariatric surgery outcomes, obesity prevalence
- MeSH terms
- Liraglutide, Female, Humans, Male, Obesity, Weight Loss, Anti-Obesity Agents, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity: a gender-view. https://app.cochat.ai/papers/10.1007/s40618-023-02196-z
- The paper
- Muscogiuri, G., Verde, L., Vetrani, C., Barrea, L., Savastano, S., & Colao, A. (2023). Obesity: a gender-view. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-023-02196-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.